The Riverside Company, a global private investor, agreed to acquire a majority stake in BioDue, a food supplements, medical devices and cosmetics company. Financial terms were not disclosed. “We are delighted to have signed this partnership with BioDue and look forward to working with the exceptional management team. BioDue operates in a large and resilient market with strong growth credentials, and the company represents an excellent foundation for pursuing growth in nutraceutical manufacturing and the branded pharma sector, both organically and through acquisitions,” Damien Gaudin, Riverside Partner.